ALUCAST LIMITED
Company number 04881298 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: ALUCAST LIMITED
1. Financial Health Score: B+ (Stable, but requiring further internal examination)
Explanation: Based on the available metadata, Alucast Limited presents as a structurally sound and long-standing entity. However, much like a patient who has skipped their annual blood work, the absence of detailed trading figures (profit & loss, cash flow) in the current dataset means we cannot give a clean bill of financial health. The score reflects strong corporate "bone density" (capital and longevity) and a healthy compliance "heartbeat," but requires further diagnostic testing to confirm overall metabolic vitality.
2. Key Vital Signs
- Corporate Longevity (Incorporation Date: August 2003): Over 20 years of active trading. This is a very positive sign. In the manufacturing sector, surviving two decades—including the 2008 financial crisis and recent pandemic disruptions—indicates a strong underlying immune system and business resilience.
- Financial Backbone (Share Capital: £303,600): A substantial share capital base acts as the company’s bone density. It shows that the owners have invested significant skin in the game, providing a thick layer of protection against minor financial fractures or short-term cash flow wounds.
- Compliance Heartbeat (Filing Status: Active, Not Overdue): The company’s accounts and confirmation statements are up to date and not overdue. This indicates a regular, healthy administrative pulse with no signs of the arrhythmia that often precedes administrative distress or insolvency.
- Ownership & Nervous System (PSCs: Two equal directors): The business is owned and controlled by two individuals (name shown to subscribers and name shown to subscribers), each holding between 25% and 50% of shares and voting rights. While this shows committed leadership, an equal split can sometimes lead to decision-making paralysis if the "neural pathways" conflict.
3. Symptoms Analysis & Diagnosis
Symptoms Analysis: Operating in SIC Code 24530 (Casting of light metals), Alucast operates in a heavy, capital-intensive industry. The company is registered as a "Group" category, which acts as a symptom of past growth—likely meaning it has subsidiary companies under its wing. This is common in manufacturing for asset protection or operational segregation, but it can also complicate the circulatory system of cash flow between entities.
The change of name from Macbeth 24 Limited shortly after incorporation in 2003 is merely a genetic marker from birth and is not a symptom of any current distress.
Diagnosis: Alucast Limited appears to be a healthy, mature manufacturing entity. There are no external symptoms of financial distress: no overdue filings, no disqualification orders against the directors, and no signs of liquidation or administration. The business has a solid foundation and a clear operational focus (aluminium casting, machining, and simulation). However, because detailed balance sheet and profit & loss metrics are currently omitted from this specific chart, we cannot definitively diagnose the strength of the company's working capital (its daily caloric intake) or its profitability.
4. Prognosis & Recommendations
Prognosis: The future outlook is cautiously optimistic, assuming the broader manufacturing sector doesn't catch a severe economic cold. The company's longevity and niche expertise in high-pressure and gravity casting provide a good defensive moat. However, the equal 50/50 ownership structure could become a vulnerability if the directors disagree on major surgeries, such as capital investment or business succession.
Recommendations to Improve Financial Wellness: 1. Conduct a Full Blood Panel (Review Detailed Accounts): To move from a B+ to an A, the detailed financial accounts must be reviewed to ensure that current assets (cash, debtors) comfortably exceed current liabilities (creditors, short-term debt). Healthy working capital is the oxygen the business needs to trade without wheezing. 2. Draft a Corporate Living Will (Shareholders' Agreement): With a 50/50 split between name shown to subscribers and name shown to subscribers, a robust shareholders' agreement is essential. This acts as a living will, ensuring that if one director wishes to exit, becomes incapacitated, or disagrees on strategic direction, the business does not suffer from decision-making paralysis. 3. Group Circulation Check (Inter-company Cash Flow): As a Group entity, ensure that cash flows between the parent and subsidiaries are healthy and not artificially inflating the parent company's balance sheet. Watch out for symptoms of one subsidiary bleeding cash to support another.